Found: 26
Select item for more details and to access through your institution.
Targeted therapy for breast cancer prevention.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00250
- By:
- Publication type:
- Article
Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa096
- By:
- Publication type:
- Article
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-019-0143-5
- By:
- Publication type:
- Article
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0118-6
- By:
- Publication type:
- Article
Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Effect of Epidermal Growth Factor Receptor Inhibitor on Development of Estrogen Receptor--Negative Mammary Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 24, p. 1825, doi. 10.1093/jnci/djg117
- By:
- Publication type:
- Article
RESPONSES: Re: Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 8, p. 658, doi. 10.1093/jnci/92.8.658
- By:
- Publication type:
- Article
RESPONSE: re: tamoxifen prevention of breast cancer: an instance of the fingerpost.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Tamoxifen Prevention of Breast Cancer: an Instance of the fingerpost.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1999, v. 91, n. 21, p. 1809, doi. 10.1093/jnci/91.21.1809
- By:
- Publication type:
- Article
cFos is critical for MCF-7 breast cancer cell growth.
- Published in:
- Oncogene, 2005, v. 24, n. 43, p. 6516, doi. 10.1038/sj.onc.1208905
- By:
- Publication type:
- Article
AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
- Published in:
- Oncogene, 2004, v. 23, n. 50, p. 8238, doi. 10.1038/sj.onc.1207889
- By:
- Publication type:
- Article
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
- Published in:
- Oncogene, 2002, v. 21, n. 50, p. 7680, doi. 10.1038/sj.onc.1205883
- By:
- Publication type:
- Article
AP-1 blockade inhibits the growth of normal and malignant breast cells.
- Published in:
- Oncogene, 2001, v. 20, n. 22, p. 2771, doi. 10.1038/sj.onc.1204377
- By:
- Publication type:
- Article
Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa .
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1162669
- By:
- Publication type:
- Article
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
- Published in:
- Oncogene, 1999, v. 18, n. 44, p. 6063, doi. 10.1038/sj.onc.1202989
- By:
- Publication type:
- Article
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 7, p. 2707, doi. 10.1172/JCI70805
- By:
- Publication type:
- Article
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Role of extracellular signal-regulated kinase pathway in RRR-α-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells.
- Published in:
- Molecular Carcinogenesis, 2002, v. 33, n. 4, p. 228, doi. 10.1002/mc.10040
- By:
- Publication type:
- Article
Activation and inhibition of the AP-1 complex in human breast cancer cells.
- Published in:
- Molecular Carcinogenesis, 1996, v. 15, n. 3, p. 215, doi. 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO;2-G
- By:
- Publication type:
- Article
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00616-8
- By:
- Publication type:
- Article
Effect of Lapatinib on the Development of Estrogen Receptor-Negative Mammary Tumors in Mice.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 2, p. 107, doi. 10.1093/jnci/djn436
- By:
- Publication type:
- Article
Molecular cancer prevention: Current status and future directions.
- Published in:
- CA: A Cancer Journal for Clinicians, 2015, v. 65, n. 5, p. 345, doi. 10.3322/caac.21287
- By:
- Publication type:
- Article
Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01814-9
- By:
- Publication type:
- Article
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01778-w
- By:
- Publication type:
- Article
Tumor-suppressor activity of RRIG1 in breast cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 32, doi. 10.1186/1471-2407-11-32
- By:
- Publication type:
- Article